Source: Temporal Trends in Phthalate Exposures: Findings from the National Health and Nutrition Examination Survey, 2001–2010 This ad-free article is made possible by the financial support of the Center for Research on Environmental Chemicals in Humans: a 501(c)(3) non-profit. Please consider making a tax-deductible donation for continued biomedical research.
Archive | Risk Assessment
Peer-reviewed evidence of endocrine disruptor risks
Halifax Project’s Special 13-Article Special Issue in the Journal “Carcinogenesis” — Available as “Seminars in Cancer Biology”
A broad-spectrum integrative design for cancer prevention and therapy: A special issue of “Seminars in Cancer Biology.” A broad-spectrum integrative design for cancer prevention and therapy: The challenge ahead Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition Sustained proliferation in cancer: Mechanisms and novel therapeutic […]
BPA & Phthalates Present in Almost All Americans
The CDC and other researchers relying on their data from the National Report on Human Exposure to Environmental Chemicals (NHANES) — study show that almost all Americans have BPA and phthalates in their bodies: 93% for BPA and up to 96% for phthalates.
Heat Shock Protein Hsp27 points to causal link between BPA and cancer & chemotherapy resistance
NOTE: This is a case study using a new precision paradigm on how to assess risks of environmental chemicals by reliance on the pharmaceutical development process and its science. More about that new paradigm at: Precision evaluation of environmental chemical risk assessment The development of a cancer’s resistance to chemotherapy has become a disheartening and […]
Precision evaluation of environmental chemical risk assessment: Using existing pharmaceutical evaluation results as a more accurate paradigm
The PharmBlocker: A new paradigm in assessing the risks of environmental chemicals PharmBlocker: An environmental chemical which acts on the identical cellular process as a pharmaceutical, but in a manner that decreases the effectiveness of the drug therapy. In plain words: If a substance is causal enough to investigate as a pharmaceutical, then it is […]
What is Peer Review And How It Can Go Wrong?
Part 1 of a 4-Part Series View Part 2 here: Peer Review, Reproducibility: How To Separate Good Science From Sketchy Tales View Part 3 here: Bad Science Thrives When Corporations & Government Regulators Deny Peer Review View Part 4 here: Private Science For Hire: Poster Children For Un-trustworthy Science To paraphrase Winston Churchill, scientific peer […]
Nano Materials As Endocrine Disruptors
NOTE: more to come. This is a “stub.” Engineered Nanomaterials: An Emerging Class of Novel Endocrine Disruptors
Bisphenol A (BPA) Risk Assessment Links
Thousands of recent, well-done studies that clearly show the dangers of BPA. However, in 2014 a lack of human resources forced the Stealth Syndromes Project to abandon thus efforts to gather and categorize studies of BPA and health because there were so many of them . Wethat it could not be done even if we […]
Original Sources: 84,000 Legal Chemicals. Fewer Than 200 Tested. Only 5 Ever Banned. Here’s Where Those Numbers Come From
By Lewis Perdue on October 22, 2014 in Featured, Risk Assessment, Why You Can’t Trust Federal & Corporate “Science”
The U.S. government allows more than 84,000 chemical compounds of unknown toxicity to be legally used in food, beverages, packaging, clothing, fabrics, personal care products, cosmetics — in any part of your environment including the air, water, or soil. Unattributed variations of that number — usually ranging from 60,000 to 80,000 — seem illogical and […]
Endocrine Disruptor Risk Assessment Link Library Launched
TO ADD OR REPORT DUPLICATES, ISSUES WITH LINKS, OR TO COMMENT ON THIS EFFORT: Please click: Send Email Regarding Endocrine Disruptor Risk Assessment Links WHY THIS EFFORT? The Endocrine Disruptor Risk Assessment Link Library is intended as a central source to track some of the thousands of peer-reviewed studies on endocrine disrupting compounds (EDCs). The […]